CPT code 88185 represents the technical component of additional flow cytometry marker testing used to characterize cell populations by cell surface, cytoplasmic, or nuclear markers. As an add-on procedure code, 88185 is reported for each additional marker beyond the primary flow cytometry panel. This code matters nationally because flow cytometry is central to diagnosing hematologic cancers, monitoring immune disorders, and guiding targeted therapies; accurate coding supports clinical communication and appropriate laboratory billing.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context and service setting for 88185, common payer coverage considerations, and an outline of the benchmarks and policy topics typically reviewed for laboratory add-on codes. The publication summarizes national reimbursement patterns and utilization drivers for flow cytometry add-on testing, highlights clinical scenarios where additional markers are commonly required, and identifies policy updates and payer guidance that affect coding and payment for laboratory technical services.

The content is intended for billing managers, laboratory directors, and health policy analysts seeking an executive-level overview of CPT code 88185 and its implications for laboratory workflows and payer interactions.